MELLISSA KING-JACOBS: Open Payments
NPI 1922568633 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 4 payments from 2 companies in 2025. Trend: 2023 $25 · 2024 $192 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 3 | $238 |
| Novo Nordisk Inc | 1 | $125 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Ozempic.
Industry payments across DC — which companies pay providers there.
